Wasatch Advisors Inc Chemo Centryx, Inc. Transaction History

Wasatch Advisors Inc

$20.1 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$15.36 - $27.51 $15.8 Million - $28.3 Million	1,027,231 Added 95.49%	2,102,953 $52.1 Million
Q1 2022 May 13, 2022	SELL	$22.22 - $39.12 $16 Million - $28.2 Million	-721,140 Reduced 40.13%	1,075,722 $27 Million
Q4 2021 Feb 15, 2022	SELL	$18.38 - $40.5 $14.3 Million - $31.5 Million	-778,173 Reduced 30.22%	1,796,862 $65.4 Million
Q3 2021 Nov 12, 2021	BUY	$13.18 - $19.83 $33.9 Million - $51.1 Million	2,575,035 New	2,575,035 $44 Million
Q2 2021 Aug 12, 2021	SELL	$9.59 - $50.88 $10.4 Million - $55.4 Million	-1,088,728 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$49.53 - $68.4 $994,364 - $1.37 Million	-20,076 Reduced 1.81%	1,088,728 $55.8 Million
Q4 2020 Feb 12, 2021	BUY	$47.25 - $65.16 $1.5 Million - $2.07 Million	31,797 Added 2.95%	1,108,804 $68.7 Million
Q3 2020 Nov 10, 2020	BUY	$46.35 - $61.69 $7.07 Million - $9.41 Million	152,558 Added 16.5%	1,077,007 $59 Million
Q2 2020 Aug 12, 2020	SELL	$38.58 - $65.07 $10.6 Million - $18 Million	-275,921 Reduced 22.99%	924,449 $53.2 Million
Q1 2020 May 08, 2020	SELL	$32.73 - $50.78 $3.3 Million - $5.11 Million	-100,706 Reduced 7.74%	1,200,370 $48.2 Million
Q4 2019 Feb 13, 2020	SELL	$6.81 - $39.55 $13 Million - $75.7 Million	-1,914,294 Reduced 59.54%	1,301,076 $51.5 Million
Q3 2019 Nov 14, 2019	BUY	$6.47 - $8.96 $1.36 Million - $1.89 Million	210,505 Added 7.01%	3,215,370 $21.8 Million
Q2 2019 Aug 07, 2019	BUY	$8.31 - $14.85 $4.49 Million - $8.02 Million	540,201 Added 21.92%	3,004,865 $0
Q1 2019 May 08, 2019	BUY	$10.01 - $13.89 $1.41 Million - $1.96 Million	141,341 Added 6.08%	2,464,664 $0
Q4 2018 Feb 14, 2019	SELL	$9.15 - $12.26 $603,268 - $808,314	-65,931 Reduced 2.76%	2,323,323 $25.3 Million
Q3 2018 Nov 07, 2018	BUY	$10.49 - $13.72 $115,295 - $150,796	10,991 Added 0.46%	2,389,254 $0
Q2 2018 Aug 02, 2018	SELL	$10.62 - $13.98 $49,584 - $65,272	-4,669 Reduced 0.2%	2,378,263 $0
Q1 2018 May 02, 2018	BUY	$5.9 - $14.99 $1.19 Million - $3.01 Million	201,044 Added 9.21%	2,382,932 $0
Q4 2017 Jan 16, 2018	SELL	$5.53 - $8.42 $203,929 - $310,504	-36,877 Reduced 1.66%	2,181,888 $0
Q3 2017 Nov 08, 2017	SELL	$6.5 - $10.69 $238,374 - $392,034	-36,673 Reduced 1.63%	2,218,765 $0
Q2 2017 Aug 16, 2017	BUY	N/A	2,255,438	2,255,438 $0

Others Institutions Holding CCXI

# of Institutions

Shares Held

66.3K

Call Options Held

Put Options Held

View Full List

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wasatch Advisors Inc with notifications on news.

Account